Fairvalue-Calculator Fairvalue-Calculator
EN DE

MariMed Inc (MRMD) Fair Value & Analysis

Healthcare · US · Market cap $27.9M

Price$0.0730
Fair Value$0.1803
Upside+147.0%
Quality95/100
Evidence: Medium Range $0.1073 – $0.2460

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

MariMed Inc (MRMD) currently trades at $0.0730, while our model-based Fair Value estimate is $0.1803 — implying the stock looks roughly 147.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

MariMed Inc. engages in cultivation, production, and selling of branded cannabis products in the United States. The company sells cannabis flower, vapes, and concentrates under the Nature's Heritage brand; and cannabis fruit chews that delivers better sleep, pain relief, stress relief, and others under Betty's Eddies brand. It offers soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; cannabis-infused hydrating drink mix for discrete and on-the-go consumption under Vibations brand; and flower, vapes, and edibles under InHouse brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is headquartered in Norwood, Massachusetts.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is MariMed Inc (MRMD) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.1803 versus a price of $0.0730 — about +147% (undervalued). Model-based estimate, not financial advice.
What is the fair value of MRMD?
Our 21-model fair value for MariMed Inc is $0.1803 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0730.
What is the quality score of MRMD?
MariMed Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.